Qiagen (QGEN) Equity Average (2009 - 2020)

Qiagen's (QGEN) quarterly Equity Average came in at $2.6 billion in Q4 2020, up 12.9% quarter-over-quarter from $2.3 billion in Q1 2015.

Qiagen (QGEN) Equity Average (2009 - 2020) Analysis & Trends

Qiagen has disclosed Equity Average across 7 years of filings, most recently posting $2.6 billion for Q4 2020.

Equity Average for Q4 2020 came in at $2.6 billion, changed N/A year-over-year; the trailing twelve-month figure through Dec 2020 was $2.6 billion (changed N/A YoY), and the FY2025 annual result was $3.7 billion, changed 0.4% from the prior year.
Equity Average came in at $2.6 billion for Q4 2020 at Qiagen, up from $2.3 billion in the prior quarter.
In the past five years, Equity Average ranged from a high of $2.6 billion in Q4 2020 to a low of $2.6 billion in Q4 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Equity Avg. (Qtr)
1	Waters	30,529.42 Bn	30,528.96 Bn	1.11 Bn	8.93 Bn
2	Thermo Fisher Scientific	183.75 Bn	180.50 Bn	7.74 Bn	52.67 Bn
3	Danaher	133.13 Bn	127.43 Bn	3.59 Bn	52.75 Bn
4	Idexx Laboratories	46.14 Bn	45.94 Bn	722.74 Mn	1.58 Bn
5	Agilent Technologies	38.20 Bn	36.39 Bn	990.00 Mn	3.35 Bn
6	Natera	31.50 Bn	30.40 Bn	696.04 Mn	1.74 Bn
7	Iqvia Holdings	31.34 Bn	29.36 Bn	1.36 Bn	6.49 Bn
8	Illumina	24.51 Bn	23.36 Bn	721.00 Mn	2.70 Bn
9	Mettler Toledo International	23.53 Bn	23.47 Bn	555.82 Mn	-32.76 Mn
10	Qiagen	8.54 Bn	7.44 Bn	-	-

Download Data